Cargando…

Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic

OBJECTIVES: We aimed to analyze the trend change of the most popular Phosphodiesterase-5 Inhibitors (PDE5i) over time and geography by using Google Trends (GT) data in 10 years period and COVID-19 pandemic. METHODS: GT is able to generate a “line-graph”, showing how interest has increased or decreas...

Descripción completa

Detalles Bibliográficos
Autores principales: Değer, Dr. Müslim D., Madendere, Dr. Serdar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679764/
http://dx.doi.org/10.1016/j.jsxm.2022.10.129
_version_ 1784834269764386816
author Değer, Dr. Müslim D.
Madendere, Dr. Serdar
author_facet Değer, Dr. Müslim D.
Madendere, Dr. Serdar
author_sort Değer, Dr. Müslim D.
collection PubMed
description OBJECTIVES: We aimed to analyze the trend change of the most popular Phosphodiesterase-5 Inhibitors (PDE5i) over time and geography by using Google Trends (GT) data in 10 years period and COVID-19 pandemic. METHODS: GT is able to generate a “line-graph”, showing how interest has increased or decreased over a period within specific territories. The search values for specific terms are indexed as relative search volume (RSV), which is presented on a scale from 0–100. Average annual percentage change (AAPC) and RSV were analyzed to evaluate gain or loss of interest in trends. Search terms were generated for Food and Drug Administration (FDA)-approved PDE5i; tadalafil, sildenafil, vardenafil, avanafil, and their most-used brand names. The data was within “worldwide” from 1 January 2010, to 31 December 2020, using the ‘‘global’’ query category. RESULTS: The overall interest in PDE5i has doubled. Sildenafil has become the most trend PDE5i of today with a regular increase (AAPC:0,016, p<0,01). Although the search trend of tadalafil remained almost constant until 2014, the rate of increase in the last 6 years raised and tadalafil has become the 2nd most popular PDE5i recently (AAPC:0,007, p<0,01). For vardenafil there has been a decreased interest (AAPC:-0,009, p<0,01). There is no significant change in avanafil trend (AAPC:0,000, p:0,5). All PDE5i interest on GT decreased notably from February to June 2020. But after June, search trends reached the level before the COVID-19 period in a month.(Figure) CONCLUSIONS: These findings show us, with its increasing prevalence, erectile dysfunction (ED) has become a major public health problem. People from different geographies search the internet for ED treatment options. Patients should be informed that ED may be the first sign of many comorbid diseases, and patients with ED should be referred to a health institution for diagnosis and treatment. CONFLICTS OF INTEREST: The study was published in Archives of Italian Urology and Andrology. (https://doi.org/10.4081/aiua.2021.3.361)
format Online
Article
Text
id pubmed-9679764
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96797642022-11-22 Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic Değer, Dr. Müslim D. Madendere, Dr. Serdar J Sex Med P-09-07 OBJECTIVES: We aimed to analyze the trend change of the most popular Phosphodiesterase-5 Inhibitors (PDE5i) over time and geography by using Google Trends (GT) data in 10 years period and COVID-19 pandemic. METHODS: GT is able to generate a “line-graph”, showing how interest has increased or decreased over a period within specific territories. The search values for specific terms are indexed as relative search volume (RSV), which is presented on a scale from 0–100. Average annual percentage change (AAPC) and RSV were analyzed to evaluate gain or loss of interest in trends. Search terms were generated for Food and Drug Administration (FDA)-approved PDE5i; tadalafil, sildenafil, vardenafil, avanafil, and their most-used brand names. The data was within “worldwide” from 1 January 2010, to 31 December 2020, using the ‘‘global’’ query category. RESULTS: The overall interest in PDE5i has doubled. Sildenafil has become the most trend PDE5i of today with a regular increase (AAPC:0,016, p<0,01). Although the search trend of tadalafil remained almost constant until 2014, the rate of increase in the last 6 years raised and tadalafil has become the 2nd most popular PDE5i recently (AAPC:0,007, p<0,01). For vardenafil there has been a decreased interest (AAPC:-0,009, p<0,01). There is no significant change in avanafil trend (AAPC:0,000, p:0,5). All PDE5i interest on GT decreased notably from February to June 2020. But after June, search trends reached the level before the COVID-19 period in a month.(Figure) CONCLUSIONS: These findings show us, with its increasing prevalence, erectile dysfunction (ED) has become a major public health problem. People from different geographies search the internet for ED treatment options. Patients should be informed that ED may be the first sign of many comorbid diseases, and patients with ED should be referred to a health institution for diagnosis and treatment. CONFLICTS OF INTEREST: The study was published in Archives of Italian Urology and Andrology. (https://doi.org/10.4081/aiua.2021.3.361) Published by Elsevier Inc. 2022-11 2022-11-22 /pmc/articles/PMC9679764/ http://dx.doi.org/10.1016/j.jsxm.2022.10.129 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle P-09-07
Değer, Dr. Müslim D.
Madendere, Dr. Serdar
Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
title Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
title_full Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
title_fullStr Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
title_full_unstemmed Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
title_short Erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
title_sort erectile dysfunction treatment with phosphodiesterase-5 inhibitors: google trends analysis of last 10 years and covid-19 pandemic
topic P-09-07
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679764/
http://dx.doi.org/10.1016/j.jsxm.2022.10.129
work_keys_str_mv AT degerdrmuslimd erectiledysfunctiontreatmentwithphosphodiesterase5inhibitorsgoogletrendsanalysisoflast10yearsandcovid19pandemic
AT madenderedrserdar erectiledysfunctiontreatmentwithphosphodiesterase5inhibitorsgoogletrendsanalysisoflast10yearsandcovid19pandemic